JPRN-UMIN000036614已完成未知
Standardization and verification of exercise for sarcopenia -randomized controlled trial- - Standardization and verification of exercise for sarcopenia -randomized controlled trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 72
研究概览
简要总结
Among the 72 participants, 67 (93.1%) completed the trial. Group-by-time interactions on the chair stand (p = 0.02) and timed "up and go" (p = 0.01) tests increased significantly in the exercise group. Although the exercise group showed a tendency to prevent loss of muscle mass, no significant interaction effects were observed for cross-sectional muscle area and muscle volume. The 12-week exercise program improved physical function in the intervention group.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 60years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Have serious or unstable illnesses 2.Care certified 3.Suspected of severe dementia 4.Judged to have a problem in the safe implementation of exercise
研究者
相似试验
已完成
不适用
A pilot study of game-based learning programs for childhood cancer survivorsJPRN-UMIN000043603Mie University Graduate School of Medicine83
进行中(未招募)
不适用
Efficacy for diabetes management index of diabetic diet intended for adult patients with type 2 diabetesEndocrine, nutritional and metabolic diseaseKCT0002217Dr.Kitchen60
已完成
2 期
A phase II study to confirm the effectiveness of a element supplement "Elental" for patients who are administered TS-1 after surgical resection (OGSG 1108)Gastric CancerJPRN-UMIN000006872Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)82
已完成
不适用
Research on effectiveness of behavioral activation therapy for Japanese cancer patients with depressioJapanese cancer patients with depressionJPRN-UMIN000036104Department of Psycho-Oncology, National Cancer Center Hospital, Japan32
已完成
不适用
A phase ll study to show the feasibility of six months continuous administration of Docetaxel+TS-1 for patients with Stage lllA/lllB gastric cancer after surgical resection (OGSG 1002)gastric cancerJPRN-UMIN000004440Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)62
